Ondine Biomedical Inc. (AIM:OBI)

Ondine Biomedical Statistics

Total Valuation

AIM:OBI has a market cap or net worth of GBP 58.86 million. The enterprise value is 56.18 million.

Market Cap	58.86M
Enterprise Value	56.18M

Important Dates

The next estimated earnings date is Wednesday, December 24, 2025.

Earnings Date	Dec 24, 2025
Ex-Dividend Date	n/a

Share Statistics

AIM:OBI has 444.23 million shares outstanding. The number of shares has increased by 68.94% in one year.

Current Share Class	444.23M
Shares Outstanding	444.23M
Shares Change (YoY)	+68.94%
Shares Change (QoQ)	+42.09%
Owned by Insiders (%)	24.92%
Owned by Institutions (%)	31.56%
Float	242.37M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	49.93
PB Ratio	151.49
P/TBV Ratio	151.49
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-4.39
EV / Sales	47.65
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-5.64

Financial Position

The company has a current ratio of 0.97, with a Debt / Equity ratio of 0.76.

Current Ratio	0.97
Quick Ratio	0.76
Debt / Equity	0.76
Debt / EBITDA	n/a
Debt / FCF	-0.03
Interest Coverage	-2,011.19

Financial Efficiency

Return on equity (ROE) is -6,414.77% and return on invested capital (ROIC) is -1,827.23%.

Return on Equity (ROE)	-6,414.77%
Return on Assets (ROA)	-235.98%
Return on Invested Capital (ROIC)	-1,827.23%
Return on Capital Employed (ROCE)	-2,475.28%
Revenue Per Employee	65,499
Profits Per Employee	-710,441
Employee Count	18
Asset Turnover	0.34
Inventory Turnover	0.58

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +65.63% in the last 52 weeks. The beta is 0.31, so AIM:OBI's price volatility has been lower than the market average.

Beta (5Y)	0.31
52-Week Price Change	+65.63%
50-Day Moving Average	14.31
200-Day Moving Average	12.14
Relative Strength Index (RSI)	45.31
Average Volume (20 Days)	182,280

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, AIM:OBI had revenue of GBP 1.18 million and -12.79 million in losses. Loss per share was -0.03.

Revenue	1.18M
Gross Profit	775,465
Operating Income	-12.92M
Pretax Income	-12.79M
Net Income	-12.79M
EBITDA	-12.69M
EBIT	-12.92M
Loss Per Share	-0.03

Balance Sheet

The company has 2.98 million in cash and 297,021 in debt, giving a net cash position of 2.68 million or 0.01 per share.

Cash & Cash Equivalents	2.98M
Total Debt	297,021
Net Cash	2.68M
Net Cash Per Share	0.01
Equity (Book Value)	388,535
Book Value Per Share	0.00
Working Capital	-145,567

Cash Flow

In the last 12 months, operating cash flow was -9.94 million and capital expenditures -12,844, giving a free cash flow of -9.96 million.

Operating Cash Flow	-9.94M
Capital Expenditures	-12,844
Free Cash Flow	-9.96M
FCF Per Share	-0.02

Margins

Gross Margin	65.77%
Operating Margin	-1,095.51%
Pretax Margin	-1,084.66%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

AIM:OBI does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-68.94%
Shareholder Yield	-68.94%
Earnings Yield	-21.73%
FCF Yield	-16.92%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

AIM:OBI has an Altman Z-Score of -51.88 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-51.88
Piotroski F-Score	3